Primary |
Alopecia |
25.7% |
Hypertension |
24.1% |
Product Used For Unknown Indication |
22.9% |
Hair Growth Abnormal |
5.0% |
Androgenetic Alopecia |
4.3% |
Blood Pressure |
2.1% |
Drug Use For Unknown Indication |
2.1% |
Depression |
1.8% |
Male Pattern Baldness |
1.6% |
Routine Health Maintenance |
1.6% |
Insomnia |
1.2% |
Accidental Exposure |
1.1% |
Bipolar Disorder |
1.1% |
Thyroid Disorder |
1.1% |
Alopecia Areata |
0.9% |
General Physical Condition |
0.9% |
Anxiety |
0.7% |
Blood Cholesterol Increased |
0.7% |
Non-small Cell Lung Cancer |
0.7% |
Antibiotic Therapy |
0.5% |
|
Pericardial Effusion |
9.4% |
Vomiting |
8.6% |
Weight Increased |
8.6% |
Psoriasis |
7.8% |
Swelling Face |
5.5% |
Toxicity To Various Agents |
5.5% |
Wrong Drug Administered |
5.5% |
Hypersensitivity |
4.7% |
Syncope |
4.7% |
Hair Growth Abnormal |
3.9% |
Oedema Peripheral |
3.9% |
Pruritus |
3.9% |
Renal Failure Acute |
3.9% |
Vertigo |
3.9% |
Visual Disturbance |
3.9% |
Wrong Technique In Drug Usage Process |
3.9% |
Arrhythmia |
3.1% |
Cardiac Disorder |
3.1% |
Cerebrovascular Accident |
3.1% |
Chest Discomfort |
3.1% |
|
Secondary |
Hypertension |
32.0% |
Product Used For Unknown Indication |
29.3% |
Alopecia |
11.9% |
Blood Pressure |
3.6% |
Drug Use For Unknown Indication |
3.5% |
Androgenetic Alopecia |
3.4% |
Hair Growth Abnormal |
3.2% |
Diabetes Mellitus |
1.8% |
Hypothyroidism |
1.2% |
Renovascular Hypertension |
1.2% |
Routine Health Maintenance |
1.2% |
Vitamin Supplementation |
1.2% |
Haemolytic Uraemic Syndrome |
0.9% |
Immunosuppression |
0.9% |
Bipolar Disorder |
0.8% |
Blood Cholesterol Increased |
0.8% |
Hyperuricaemia |
0.8% |
Infection |
0.8% |
Insomnia |
0.8% |
Mineral Supplementation |
0.8% |
|
Vomiting |
9.6% |
Psoriasis |
8.8% |
Wrong Drug Administered |
7.9% |
Hypertension |
6.1% |
Toxicity To Various Agents |
6.1% |
Death |
5.3% |
Alopecia |
4.4% |
Completed Suicide |
4.4% |
Herpes Virus Infection |
4.4% |
Hyponatraemia |
4.4% |
Myocardial Infarction |
4.4% |
Tinnitus |
4.4% |
Weight Increased |
4.4% |
Wrong Technique In Drug Usage Process |
4.4% |
Abdominal Distension |
3.5% |
Blood Pressure Fluctuation |
3.5% |
Blood Pressure Increased |
3.5% |
Cerebral Infarction |
3.5% |
Drug Ineffective |
3.5% |
Overdose |
3.5% |
|
Concomitant |
Product Used For Unknown Indication |
34.0% |
Drug Use For Unknown Indication |
20.8% |
Hypertension |
14.0% |
Nuclear Magnetic Resonance Imaging |
6.5% |
Angiogram |
2.5% |
Alopecia |
2.0% |
Renal Transplant |
1.9% |
Pain |
1.9% |
Hyperparathyroidism Secondary |
1.9% |
Dialysis |
1.7% |
Blood Pressure |
1.6% |
Nuclear Magnetic Resonance Imaging Brain |
1.5% |
Peritoneal Dialysis |
1.4% |
Renal Failure Chronic |
1.4% |
Diabetes Mellitus |
1.3% |
Blood Cholesterol Increased |
1.2% |
Prophylaxis |
1.2% |
Anaemia |
1.2% |
Rheumatoid Arthritis |
1.0% |
Prophylaxis Against Transplant Rejection |
0.9% |
|
Vomiting |
17.2% |
Therapeutic Response Decreased |
8.8% |
Weight Decreased |
8.1% |
Thrombocytopenia |
6.4% |
Pneumonia |
5.7% |
Drug Ineffective |
4.4% |
Spinal Osteoarthritis |
4.4% |
Syncope |
4.4% |
Nephrogenic Systemic Fibrosis |
3.7% |
Pruritus |
3.7% |
Skin Tightness |
3.7% |
Tremor |
3.7% |
Pain |
3.4% |
Progressive Multifocal Leukoencephalopathy |
3.4% |
Renal Failure Acute |
3.4% |
White Blood Cell Count Increased |
3.4% |
Haemoglobin Decreased |
3.0% |
Nausea |
3.0% |
Renal Failure |
3.0% |
Sepsis |
3.0% |
|
Interacting |
Blood Pressure Abnormal |
60.0% |
Renal Cell Carcinoma |
20.0% |
Thyroid Disorder |
20.0% |
|
|